Phenotype of retrovirally transduced CTLs
Recipient dog . | Donor dog . | Percent specific lysis . | Percent CD3+ . | Percent CD8+ . | Percent CD4+ . | Percent transduced . | Vector . |
---|---|---|---|---|---|---|---|
E646 | E651 | 48 | 98.2 | 91.8 | 19.4 | 14.1* | NGFR |
E644 | E642 | 69 | 97.7 | 96.7 | 5.5 | 97.7 | GFP |
E650 | E659 | 44 | 99.3 | 88.7 | 12.1 | 96.1 | GFP |
E655 | E640 | 57 | 97.5 | 95.5 | 12.4 | 94.4 | GFP |
E714 | E715 | 82 | 97.1 | 97.1 | 13.5 | 94.1 | GFP |
E671 | E670 | 70 | 98.4 | 99.1 | 6.2 | 93.1 | GFP |
E746 | E748 | 68 | 99.4 | 96.6 | 7.8 | 84.2 | GFP |
E716 | E718 | 71 | 98.3 | 99.7 | 7.7 | 93.4 | GFP |
E815 | E817 | 80 | 99.9 | 99.8 | 11.8 | 98.3 | GFP |
E801 | E803 | 74 | 99.9 | 99.4 | 18.7 | 98.4 | GFP |
E755 | E753 | 52 | 99.9 | 97.2 | 88.7 | 98.8 | GFP |
Recipient dog . | Donor dog . | Percent specific lysis . | Percent CD3+ . | Percent CD8+ . | Percent CD4+ . | Percent transduced . | Vector . |
---|---|---|---|---|---|---|---|
E646 | E651 | 48 | 98.2 | 91.8 | 19.4 | 14.1* | NGFR |
E644 | E642 | 69 | 97.7 | 96.7 | 5.5 | 97.7 | GFP |
E650 | E659 | 44 | 99.3 | 88.7 | 12.1 | 96.1 | GFP |
E655 | E640 | 57 | 97.5 | 95.5 | 12.4 | 94.4 | GFP |
E714 | E715 | 82 | 97.1 | 97.1 | 13.5 | 94.1 | GFP |
E671 | E670 | 70 | 98.4 | 99.1 | 6.2 | 93.1 | GFP |
E746 | E748 | 68 | 99.4 | 96.6 | 7.8 | 84.2 | GFP |
E716 | E718 | 71 | 98.3 | 99.7 | 7.7 | 93.4 | GFP |
E815 | E817 | 80 | 99.9 | 99.8 | 11.8 | 98.3 | GFP |
E801 | E803 | 74 | 99.9 | 99.4 | 18.7 | 98.4 | GFP |
E755 | E753 | 52 | 99.9 | 97.2 | 88.7 | 98.8 | GFP |
Percent specific lysis denotes cytotoxicity by 51Cr release assay at an effector-target ratio of 20:1.
Not selected in G418.